Ticabid-A Combikit

Przegląd produktu

About Ticabid-A Combikit

Ticabid-A Combikit is a medication containing the active ingredient ticagrelor, classified as P2Y12 Platelet Inhibitor. Ticagrelor, sold under the brand name Brilinta among others, is a medication used for the prevention of stroke, heart attack and other events in people with acute coronary syndrome, meaning problems with blood supply in the coronary arteries.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE Ticagrelor is a P2Y 12 platelet inhibitor indicated to reduce the risk of cardiovascular (CV) death, myocardial infarction.
• Use only as directed on the product label or by a healthcare professional.
• Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

ticagrelor, the active ingredient in Ticabid-A Combikit, belongs to the P2Y12 Platelet Inhibitor class. 1 INDICATIONS AND USAGE Ticagrelor is a P2Y 12 platelet inhibitor indicated to reduce the risk of cardiovascular (CV) death, myocardial infarction (MI), and stroke in patients with acute coronary syndrome (ACS) or a history of myocardial infarction (MI). Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Ticabid-A Combikit. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Ticabid-A Combikit for extended periods without medical advice.